Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review

•Genomic alterations in PDAC represent potential targeting opportunities to individualize therapy.•Attempts to target key somatic driver mutations in PDAC have been unsuccessful.•DNA-damage repair gene mutations confer vulnerability to platinum agents and PARP-inhibitors.•Microsatellite unstable PDA...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer treatment reviews Ročník 75; s. 27 - 38
Hlavní autoři:	Singh, Ritu R., Goldberg, Johanna, Varghese, Anna M., Yu, Kenneth H., Park, Wungki, O'Reilly, Eileen M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.05.2019
Témata:	Animals Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - genetics DNA damage repair DNA Repair - drug effects DNA Repair - genetics Genomic alteration (GA) Genomics - methods Germline mutation Humans Microsatellite instability Mismatch repair (MMR) Pancreatic ductal adenocarcinoma (PDAC) Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - genetics Poly(ADP-ribose) Polymerase Inhibitors - pharmacology Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use Somatic mutation Somatic mutation Mismatch repair (MMR) DNA damage repair Pancreatic ductal adenocarcinoma (PDAC) Genomic alteration (GA) Germline mutation Microsatellite instability
ISSN:	0305-7372, 1532-1967, 1532-1967
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!